Sample TOC - Global Biobanking Market 2017 20231

BIOBANKING MARKET
Global Opportunity Analysis and Industry Forecast,

2017–2023
5933 NE Win Sivers Drive | #205 |

Portland | OR 97220 | United States |
Int'l: +1-503-894-6022
Global Biobanking Market, 2017–2023
ABOUT US
Allied Market Research is a full-service market research and business-consulting wing of Allied Analytics LLP based in
Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with
unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to
provide business insights and consulting to assist its clients to make strategic business decisions and achieve
sustainable growth in their respective market domain.
TERMS OF USE
The electronic or hard copy of this report bears an underlying contractual agreement between Allied Market Research
and the buyer. The complete or part of the content of the report cannot be shared or made available to other persons,
other divisions, subsidiaries of same company or other companies. The reproduction or redistribution of the report in
any manner is strictly prohibited without the prior permission of Allied Market Research. The publisher will, in-turn,
regard the privacy of the purchaser and will keep it confidential. In case the purchaser wishes to share the content of
the report or the report proceeds with other members or departments of company, the license technology of the report
should be upgraded depending upon the sharing requirement. Additional copies for this report may also be order at
discounted price for use by addition readers/users. This publication is informative material and is not meant for
managerial, legal or accounting advice. It should not be used for corporate guide, laboratory manual or endorsement of
any product.
2
Copyright © Allied Market Research | sales@alliedmarketresearch.com | www.alliedmarketresearch.com
CUSTOM STUDIES
Allied Market Research also offers custom studies completely tailored to the needs of the clients in area related to this
study; however, may not be covered in detail in this report. The report can be customized up to an extent of 10% within
the scope of the study without any charge. For further customization, please contact us regarding such services.
LICENSE AGREEMENT
The license terms and conditions stated herein (the "License Terms" hereafter) facilitates the use of
product(s)/service(s) ("report") offered by "Allied Market Research ("AMR") in any form and is applicable to all orders
(an "Order"). By placing the order, an individual ("you") on his/her own or on behalf of the 'organization', agrees to the
license terms. The license terms shall be binding upon acceptance and delivery of research products (includes research
reports, survey data, company profiles, custom research services and any other product created and owned by AMR) or
consulting assignments by AMR and any of its authorized distributors. Our publications are available in Single-User
License, Group-User License, Site-User License and Global User License.
3
TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
4
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4 BIOBANKING MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast

4.2. EQUIPMENTS
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast by region
4.2.3. Market size and forecast by country
4.2.4. Refrigerators
4.2.4.1. Market size and forecast
4.2.5. Ice Machines Freezers
4.2.6. Cryogenic Storage Systems
5
4.2.7. Alarm Monitoring Systems
4.2.8. LN2 Supply Tanks

4.3. CONSUMABLES
4.3.4. Optimized Pre-Formulated Media
4.3.5. Non-optimized Isotonic Formulated Media
4.4. SERVICES
6
4.5. SOFTWARES
CHAPTER 5 BIOBANKING MARKET, BY SAMPLE TYPE
5.1. OVERVIEW
5.2. BLOOD PRODUCTS
5.3. HUMAN TISSUES
5.4. NUCLEIC ACIDS
7
5.5. CELL LINES
5.6. BIOLOGICAL FLUIDS
5.7. HUMAN WASTE PRODUCTS
5.8. OTHER SAMPLES
CHAPTER 6 BIOBANKING MARKET, BY APPLICATION
6.1. OVERVIEW
8
6.2. DRUG DISCOVERY
6.3. REGENERATIVE MEDICINE
6.4. CLINICAL RESEARCH
6.5. LIFE SCIENCE RESEARCH
6.6. OTHER APPLICATIONS
9
CHAPTER 7 BIOBANKING MARKET, BY REGION
7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.2. North America Biobanking Market by Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Biobanking Market by Product

7.2.2.1.2. U.S. Biobanking Market by Sample Type
7.2.2.1.3. U.S. Biobanking Market by Application
7.2.2.2. Canada
7.2.2.2.1. Canada Biobanking Market by Product

7.2.2.2.2. Canada Biobanking Market by Sample Type
7.2.2.2.3. Canada Biobanking Market by Application
7.2.2.3. Mexico
7.2.2.3.1. Mexico Biobanking Market by Product

7.2.2.3.2. Mexico Biobanking Market by Sample Type
7.2.2.3.3. Mexico Biobanking Market by Application
10
7.2.3. North America Biobanking Market by Product
7.2.4. North America Biobanking Market by Sample Type
7.2.5. North America Biobanking Market by Application
7.3. EUROPE
7.3.2. Europe BiobankingMarket by Country
7.3.2.1. Germany
7.3.2.1.1. Germany Biobanking Market by Product

7.3.2.1.2. Germany Biobanking Market by Sample Type
7.3.2.1.3. Germany Biobanking Market by Application
7.3.2.2. France
7.3.2.2.1. France Biobanking Market by Product

7.3.2.2.2. France Biobanking Market by Sample Type
7.3.2.2.3. France Biobanking Market by Application
7.3.2.3. UK
7.3.2.3.1. UK Biobanking Market by Product

7.3.2.3.2. UK Biobanking Market by Sample Type
7.3.2.3.3. UK Biobanking Market by Application
11
7.3.2.4. Italy
7.3.2.4.1. Italy Biobanking Market by Product

7.3.2.4.2. Italy Biobanking Market by Sample Type
7.3.2.4.3. Italy Biobanking Market by Application
7.3.2.5. Spain
7.3.2.5.1. Spain Biobanking Market by Product

7.3.2.5.2. Spain Biobanking Market by Sample Type
7.3.2.5.3. Spain Biobanking Market by Application
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe Biobanking Market by Product

7.3.2.6.2. Rest of Europe Biobanking Market by Sample
Type
7.3.2.6.3. Rest of Europe Biobanking Market by Application
7.3.3. Europe Biobanking Market by Product
7.3.4. Europe Biobanking Market by Sample Type
7.3.5. Europe Biobanking Market by Application
12
7.4. ASIA-PACIFIC
7.4.2. Asia-Pacific Biobanking Market by Country
7.4.2.1. Japan
7.4.2.1.1. Japan Biobanking Market by Product

7.4.2.1.2. Japan Biobanking Market by Sample Type
7.4.2.1.3. Japan Biobanking Market by Application
7.4.2.2. China
7.4.2.2.1. China Biobanking Market by Product

7.4.2.2.2. China Biobanking Market by Sample Type
7.4.2.2.3. China Biobanking Market by Application
7.4.2.3. Australia
7.4.2.3.1. Australia Biobanking Market by Product

7.4.2.3.2. Australia Biobanking Market by Sample Type
7.4.2.3.3. Australia Biobanking Market by Application
13
7.4.2.4. India
7.4.2.4.1. India Biobanking Market by Product

7.4.2.4.2. India Biobanking Market by Sample Type
7.4.2.4.3. India Biobanking Market by Application
7.4.2.5. South Korea
7.4.2.5.1. South Korea Biobanking Market by Product

7.4.2.5.2. South Korea Biobanking Market by Sample Type
7.4.2.5.3. South Korea Biobanking Market by Application
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific Biobanking Market by

Product
7.4.2.6.2. Rest of Asia-Pacific Biobanking Market by Sample
Type
7.4.2.6.3. Rest of Asia-Pacific Biobanking Market by
Application
7.4.3. Asia-Pacific Biobanking Market by Product
7.4.4. Asia-Pacific Biobanking Market by Sample Type
7.4.5. Asia-Pacific Biobanking Market by Application
14
7.5. LAMEA
7.5.2. LAMEA Biobanking Market by Country
7.5.2.1. Brazil
7.5.2.1.1. Brazil Biobanking Market by Product

7.5.2.1.2. Brazil Biobanking Market by Sample Type
7.5.2.1.3. Brazil Biobanking Market by Application
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia Biobanking Market by Product

7.5.2.2.2. Saudi Arabia Biobanking Market by Sample Type
7.5.2.2.3. Saudi Arabia Biobanking Market by Application
7.5.2.3. South Africa
7.5.2.3.1. South Africa Biobanking Market by Product

7.5.2.3.2. South Africa Biobanking Market by Sample Type
7.5.2.3.3. South Africa Biobanking Market by Application
15
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA Biobanking Market by Product

7.5.2.4.2. Rest of LAMEA Biobanking Market by Sample
Type
7.5.2.4.3. Rest of LAMEA Biobanking Market by Application
7.5.3. LAMEA Biobanking Market by Product
7.5.4. LAMEA Biobanking Market by Sample Type
7.5.5. LAMEA Biobanking Market by Application
CHAPTER 8 COMPANY PROFILES
8.1. ATLANTA BIOLOGICALS

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. BECKMAN COULTER, INC.

16
8.3. BIOCISION, LLC

8.4. BIOLIFE SOLUTIONS, INC.

8.5. CELL & CO BIOSERVICES

8.6. SO-LOW ENVIRONMENTAL EQUIPMENT CO.

17
8.7. TAYLOR-WHARTON INTERNATIONAL LLC
8.8. TECAN TRADING AG

8.9. THERMO FISHER SCIENTIFIC INC.
8.10. VWR INTERNATIONAL LLC

*Details on financial performance, strategic moves and developments may not be captured for unlisted companies.
* Please note this is a tentative TOC and may change with research proceedings.
18
SAMPLE TABLES
TABLE 1. GLOBAL BIOBANKING MARKET, BY PRODUCT, 2016–2023 ($MILLION)
CAGR %
Product 2016 2017 2018 2019 2020 2021 2022 2023
(2017-2023)
Equipments XX XX XX XX XX XX XX XX XX
Consumables XX XX XX XX XX XX XX XX XX
Services XX XX XX XX XX XX XX XX XX
Software XX XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX XX
Source: Secondary Research, Primary Research, Government Publications, Company Releases, and AMR Analysis
TABLE 2. BIOBANKING MARKET FOR EQUIPMENTS, BY REGION, 2016–2023 ($MILLION)

CAGR %
Region 2016 2017 2018 2019 2020 2021 2022 2023
(2017-2023)
North America XX XX XX XX XX XX XX XX XX
Europe XX XX XX XX XX XX XX XX XX
Asia-Pacific XX XX XX XX XX XX XX XX XX
LAMEA XX XX XX XX XX XX XX XX XX
19
TABLE 3. GLOBAL BIOBANKING MARKET, BY SAMPLE TYPE, 2016–2023 ($MILLION)

CAGR %
Sample Type 2016 2017 2018 2019 2020 2021 2022 2023
(2017-2023)
Blood Products XX XX XX XX XX XX XX XX XX
Human Tissues XX XX XX XX XX XX XX XX XX
Nucleic Acids XX XX XX XX XX XX XX XX XX
Cell Lines XX XX XX XX XX XX XX XX XX
Biological Fluids XX XX XX XX XX XX XX XX XX
Human Waste Products XX XX XX XX XX XX XX XX XX
Other Samples XX XX XX XX XX XX XX XX XX
TABLE 4. GLOBAL BIOBANKING MARKET, BY APPLICATION, 2016–2023 ($MILLION)

CAGR %
Application 2016 2017 2018 2019 2020 2021 2022 2023
(2017-2023)
Drug Discovery XX XX XX XX XX XX XX XX XX
Regenerative Medicine XX XX XX XX XX XX XX XX XX
Clinical Research XX XX XX XX XX XX XX XX XX
Life Science Research XX XX XX XX XX XX XX XX XX
Other Applications XX XX XX XX XX XX XX XX XX
20
TABLE 5. GLOBAL BIOBANKING MARKET, BY REGION, 2016–2023 ($MILLION)

CAGR %
Region 2016 2017 2018 2019 2020 2021 2022 2023
(2017-2023)
North America XX XX XX XX XX XX XX XX XX
Europe XX XX XX XX XX XX XX XX XX
Asia-Pacific XX XX XX XX XX XX XX XX XX
LAMEA XX XX XX XX XX XX XX XX XX
21
SAMPLE FIGURE
FIGURE 1. BIOBANKING MARKET FOR EQUIPMENT, BY COUNTRY, 2016 AND 2023
($MILLION)
U.S.
Canada
Mexico
Germany
France
UK
Italy
Spain
Rest of Europe
2016 Japan 2023
China
Australia
India
South Korea
Rest of Asia-Pacific
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
22
DISCLAIMER
In response to request/orders received, Allied Market Research (AMR) provides strategic business/market analysis
services to a select group of customers that are limited to publications containing valuable market information. The
publication is solely for our customers’ internal use. It is acknowledged by our customer, by placing the order that no
part of this strategic business/market analysis service is for general publication or disclosure to third party.
AMR doesn’t make any warranty for the accuracy of the data as these are primarily based on interviews and therefore,
liable for fluctuation. Also, AMR doesn’t take responsibility for incorrect information supplied by manufacturers or
users.
Any resale, lending, disclosure or reproduction of this publication can only be made with prior written permission from
AMR.
Transmission and/or reproduction of this document by any means or in any form (includes photocopying, mechanical,
electronic, recording or otherwise) are prohibited without permission of AMR.
For information regarding permissions, contact:

Tel: +1 (503 894-6022)
Email: sales@alliedmarketresearch.com
23

Sample TOC - Global Biobanking Market 2017 20231

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Sample TOC - Global Biobanking Market 2017 20231

Uploaded by

Copyright:

Available Formats

BIOBANKING MARKET

Global Opportunity Analysis and Industry Forecast,

5933 NE Win Sivers Drive | #205 |

1.1. REPORT DESCRIPTION

1.2. KEY BENEFITS

1.3. KEY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. KEY FINDINGS

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016

3.4. MARKET DYNAMICS

CHAPTER 4 BIOBANKING MARKET, BY PRODUCT

4.1.1. Market size and forecast

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast by region

4.2.3. Market size and forecast by country

4.2.4.1. Market size and forecast

4.2.5. Ice Machines Freezers

4.2.5.1. Market size and forecast

4.2.6. Cryogenic Storage Systems

4.2.6.1. Market size and forecast

4.2.7. Alarm Monitoring Systems

4.2.7.1. Market size and forecast

4.2.8. LN2 Supply Tanks

4.2.8.1. Market size and forecast

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast by region

4.3.3. Market size and forecast by country

4.3.4. Optimized Pre-Formulated Media

4.3.4.1. Market size and forecast

4.3.5. Non-optimized Isotonic Formulated Media

4.3.5.1. Market size and forecast

4.4.2. Market size and forecast by region

4.4.3. Market size and forecast by country

4.5.2. Market size and forecast by region

4.5.3. Market size and forecast by country

CHAPTER 5 BIOBANKING MARKET, BY SAMPLE TYPE

5.1.1. Market size and forecast

5.2. BLOOD PRODUCTS

5.2.1. Market size and forecast by region

5.2.2. Market size and forecast by country

5.3. HUMAN TISSUES

5.3.1. Market size and forecast by region

5.3.2. Market size and forecast by country

5.4. NUCLEIC ACIDS

5.4.1. Market size and forecast by region

5.4.2. Market size and forecast by country

5.5. CELL LINES

5.5.1. Market size and forecast by region

5.5.2. Market size and forecast by country

5.6. BIOLOGICAL FLUIDS

5.6.1. Market size and forecast by region

5.6.2. Market size and forecast by country

5.7. HUMAN WASTE PRODUCTS

5.7.1. Market size and forecast by region